WuXi Advanced Therapies, the advanced therapies unit of WuXi AppTec, is a leading cell and gene therapy contract testing, development, and manufacturing organization (CTDMO). The company leverages scalable, integrated platforms and testing to reducing the complexities of manufacturing, expediting development, manufacture, and commercialization while reducing risk. Since 2018, it has leveraged its extensive state-of-the-art, GMP-compliant facilities to help clients overcome challenges and achieve greater predictability and speed to clinic.
